Important: VAERS reports alone cannot determine if a vaccine caused an adverse event. Reports may contain incomplete, inaccurate, or unverified information. Correlation does not equal causation.
#3 most reported symptom for this vaccine
Injection site erythema has been reported 11,724 times in association with Varicella (Varivax) vaccination in VAERS. This represents 12.6% of all 93,126 reports for this vaccine.
Among these reports, 0 mentioned death (0.00%) and 124 involved hospitalization (1.1%).
Injection site erythema is the #3 most frequently reported symptom for Varicella (Varivax) out of 2205 total symptoms.
Disclaimer: VAERS reports describe events that occurred after vaccination but do not establish that the vaccine caused the event. Many reported symptoms may be coincidental or related to underlying conditions.
Seeing 11,724 reports of Injection site erythema after Varicella (Varivax) vaccination may seem alarming, but context is critical.
The mortality rate among these reports is very low at 0.00%, suggesting most cases are non-fatal.
This data comes from the Vaccine Adverse Event Reporting System (VAERS), jointly managed by CDC and FDA.